MAYBAKER
HEALTHCARE NGXMAYBAKER
closing price · trade date July 21, 2026
Key Trading Data
Latest imported Nigerian Exchange session data.
About MAYBAKER
May & Baker Nigeria Plc is a pioneering healthcare and pharmaceutical manufacturing company listed on the Nigerian Exchange, specializing in the production of high-quality medicines and consumer health products.
Established in 1944, May & Baker is one of Nigeria's oldest pharmaceutical companies. Over the decades, it has evolved from a sales and distribution outpost into a major player in the West African healthcare landscape, producing a wide array of therapeutic formulations and consumer health products.
The company's operations are supported by its manufacturing facility in Ota, Ogun State. This facility allows May & Baker to maintain high-quality production pipelines for essential medications, ensuring the local market has consistent access to critical pharmaceutical therapeutics.
Through strategic partnerships, including a joint venture with the Federal Government of Nigeria under Biovaccines Nigeria Limited, the company aims to support local vaccine production. This initiative is intended to support Nigeria's vaccine self-sufficiency and public-health preparedness, subject to execution and regulatory progress.
Fundamentals & Ratios
Company metrics where available.
Local Manufacturing Capacity
The company operates a pharmaceutical manufacturing facility in Ota, Ogun State, which the company has described as built to international/GMP standards. This facility supports domestic production of pharmaceutical and consumer health products, as well as the company's overall manufacturing and distribution operations.
Strategic Initiatives in Immunization
May & Baker has a joint-venture relationship with the Federal Government through Biovaccines Nigeria Limited aimed at local vaccine production. This initiative is intended to support Nigeria's vaccine self-sufficiency and public-health preparedness, subject to execution and regulatory progress.